{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T13:03:24Z","timestamp":1763125404997,"version":"3.45.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"crossref","award":["2024NSCQ-MSX3234"],"award-info":[{"award-number":["2024NSCQ-MSX3234"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Innovation Ability Enhancement Project of Army Medical University","award":["2023XQN47"],"award-info":[{"award-number":["2023XQN47"]}]},{"name":"Chongqing Clinical Research Centre of Imaging and Nuclear Medicine","award":["CSTC2015YFPT-gcjsyjzx0175"],"award-info":[{"award-number":["CSTC2015YFPT-gcjsyjzx0175"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>\n                    A 37-year-old woman with recurrent glioblastoma in the right temporo-occipital lobe after surgery exhibited contrast-enhanced foci on contrast-enhanced MRI, with mild tracer uptake on\n                    <jats:sup>11<\/jats:sup>\n                    C-methionine PET\/MRI and significantly increased tracer uptake on\n                    <jats:sup>18<\/jats:sup>\n                    F-NOTA-NFB, an\n                    <jats:sup>18<\/jats:sup>\n                    F-labeled chemokine receptor-4\u2013targeted PET tracer, PET\/MRI.\n                    <jats:sup>18<\/jats:sup>\n                    F-NOTA-NFB PET showed a significantly higher tumor-to-background ratio for recurrence than\n                    <jats:sup>11<\/jats:sup>\n                    C-methionine PET, allowing a more precise visualization of recurrent lesions. This case indicates that\n                    <jats:sup>18<\/jats:sup>\n                    F-NOTA-NFB PET\/MRI might give advantages in glioma delineation that might provide valuable information for making a treatment strategy and personalized radiotherapy planning.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006059","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T19:00:09Z","timestamp":1752260409000},"page":"1229-1230","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of 18F-NOTA-NFB and 11C-Methionine PET\/MRI in Detecting Glioma Recurrence"],"prefix":"10.1097","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6710-6323","authenticated-orcid":false,"given":"Zhenwei","family":"Du","sequence":"first","affiliation":[{"name":"Nuclear Medicine"},{"name":"Medical Engineering"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Long","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiguo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Radiology, Daping Hospital, Army Medical University"},{"name":"Chongqing Clinical Research Center for Imaging and Nuclear Medicine, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"},{"name":"Chongqing Clinical Research Center for Imaging and Nuclear Medicine, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"R1-20251114","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11060-022-04123-3","article-title":"Relapse patterns and radiation dose exposure in IDH wild-type glioblastoma at first radiographic recurrence following chemoradiation","volume":"160","author":"Shidoh","year":"2022","journal-title":"J Neurooncol"},{"key":"R2-20251114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-009-9897-1","article-title":"Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities","volume":"95","author":"Alexiou","year":"2009","journal-title":"J Neurooncol"},{"key":"R3-20251114","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/neuonc\/now058","article-title":"Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas","volume":"18","author":"Albert","year":"2016","journal-title":"Neuro Oncol"},{"key":"R4-20251114","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/neuonc\/noab013","article-title":"Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients\u2014a report of the PET\/RANO group","volume":"23","author":"Galldiks","year":"2021","journal-title":"Neuro Oncol"},{"key":"R5-20251114","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11060-013-1108-4","article-title":"The role of the CXCR4 cell surface chemokine receptor in glioma biology","volume":"113","author":"Ehtesham","year":"2013","journal-title":"J Neurooncol"},{"key":"R6-20251114","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1007\/s00259-022-06059-2","article-title":"[(68)Ga]Ga-Pentixafor PET\/CT imaging for in vivo CXCR4 receptor mapping in different lung cancer histologic sub-types: correlation with quantitative receptors\u2019 density by immunochemistry techniques","volume":"50","author":"Watts","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R7-20251114","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00259-021-05196-4","article-title":"CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [(68)Ga]Ga-Pentixafor \/[(177)Lu]Lu-Pentixather","volume":"49","author":"Jacobs","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R8-20251114","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1097\/RLU.0000000000005073","article-title":"68 Ga-Pentixafor PET\/CT for in vivo imaging of CXCR4 receptors in glioma demonstrating a potential for response assessment to radiochemotherapy: preliminary results","volume":"49","author":"Waheed","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R9-20251114","doi-asserted-by":"crossref","first-page":"111694","DOI":"10.1016\/j.ejrad.2024.111694","article-title":"[(68) Ga]Ga-CXCR4 PET\/CT imaging in high-grade glioma for assessment of CXCR4 receptor expression","volume":"180","author":"Roustaei","year":"2024","journal-title":"Eur J Radiol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T13:00:39Z","timestamp":1763125239000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006059","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"type":"print","value":"0363-9762"},{"type":"electronic","value":"1536-0229"}],"subject":[],"published":{"date-parts":[[2025,7,11]]},"assertion":[{"value":"2025-04-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}